XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Net Loss Per Share (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Earnings Per Share [Abstract] |
Summary of Basic and Diluted Net Loss Per Share | The following table outlines the basic and diluted net loss per share for the three months ended March 31, 2024 and 2023:
|  |  |  | Three Months Ended March 31,
(in thousands, except per share data) |  |  |  |  |  | 2024 |  | 2023
Net loss |  |  |  |  |  | $ | (18,961) |  |  | $ | (6,100) |
Weighted-average shares outstanding, basic and diluted |  |  |  |  |  | 100,755 |  |  | 99,158 |
Net loss per share, basic and diluted |  |  |  |  |  | $ | (0.19) |  |  | $ | (0.06) |
Summary of Dilutive Common Shares | The following table outlines dilutive common share equivalents outstanding, which are excluded in the above diluted net loss per share calculation, as the effect of their inclusion would be anti-dilutive, or the share equivalents were contingently issuable as of each period presented:
| March 31,
| 2024 |  | 2023
Options to purchase common stock issued and outstanding(1) | 22,437,492 |  |  | 18,735,538 |
Earnout shares | 16,292,542 |  |  | 16,292,542 |
Avista private placement warrants | 8,233,333 |  |  | 8,233,333 |
Avista public warrants | 7,666,667 |  |  | 7,666,667 |
Restricted stock units issued and outstanding(1) | 2,421,767 |  |  | 1,710,065 |
Forward purchase warrants | 1,666,667 |  |  | 1,666,667 |
Backstop warrants | 1,445,489 |  |  | 1,445,489 |
Shares expected to be purchased under employee stock purchase plan | 946,670 |  |  | 1,918,512 |
Total anti-dilutive shares | 61,110,627 |  |  | 57,668,813 |
_____________ (1)Outstanding stock options and restricted stock units include awards outstanding to employees of Ligand.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration